H
Hannu Koistinen
Researcher at University of Helsinki
Publications - 139
Citations - 4722
Hannu Koistinen is an academic researcher from University of Helsinki. The author has contributed to research in topics: Glycodelin & Cancer. The author has an hindex of 40, co-authored 129 publications receiving 4387 citations. Previous affiliations of Hannu Koistinen include Helsinki University Central Hospital & GlaxoSmithKline.
Papers
More filters
Journal ArticleDOI
Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3.
Maija Harrela,Hannu Koistinen,Jaakko Kaprio,Mikko Lehtovirta,J. Tuomilehto,Johan G. Eriksson,L Toivanen,Markku Koskenvuo,Pekka Leinonen,R Koistinen,Markku Seppälä +10 more
TL;DR: It is shown that, in adults, there is a substantial genetic contribution responsible for interindividual variation of the circulating levels of IGF-I, IGF-II, and IGFBP-3, but not for the IGF BP-1 levels.
Journal ArticleDOI
Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities.
Anne Dell,Howard R. Morris,Richard L. Easton,Maria Panico,Manish S. Patankar,Sergio Oehninger,Riitta Koistinen,Hannu Koistinen,Markku Seppälä,Gary F. Clark +9 more
TL;DR: The potent inhibitory effect of glycodelin on initial human sperm-zona pellucida binding is consistent with previous suggestion that this cell adhesion event requires a selectin-like adhesion process and raises the possibility that a convergence between immune and gamete recognition processes may have occurred in the types of carbohydrate ligands recognized in the human.
Journal ArticleDOI
Glycodelin: A Major Lipocalin Protein of the Reproductive Axis with Diverse Actions in Cell Recognition and Differentiation
TL;DR: Along with being an epithelial differentiation marker, glycodelin appears to play a role in glandular morphogenesis, as transfection of gly codelin cDNA into a glyCodelin-negative breast cancer cells resulted in formation of gland-like structures, restricted proliferation, and induction of other epithelial markers.
Journal ArticleDOI
Insulin Reduction with Metformin Increases Luteal Phase Serum Glycodelin and Insulin-Like Growth Factor-Binding Protein 1 Concentrations and Enhances Uterine Vascularity and Blood Flow in the Polycystic Ovary Syndrome
Daniela Jakubowicz,Markku Seppälä,Salomon Jakubowicz,Otto Rodriguez-Armas,Asdrubal Rivas-Santiago,Hannu Koistinen,Riitta Koistinen,John E. Nestler +7 more
TL;DR: It is concluded that insulin reduction with metformin increases follicular and luteal phase serum glycodelin and insulin-like growth factor-binding protein-1 concentrations and enhances lutesal phase uterine vascularity and blood flow in the polycystic ovary syndrome.
Journal ArticleDOI
Gender-specific Glycosylation of Human Glycodelin Affects Its Contraceptive Activity
Howard R. Morris,Anne Dell,Richard L. Easton,Maria Panico,Hannu Koistinen,Riitta Koistinen,Sergio Oehninger,Manish S. Patankar,Markku Seppälä,Gary F. Clark +9 more
TL;DR: This study provides the first evidence for gender-specific glycosylation that may serve to regulate key processes involved in human reproduction and contribute to the immunosuppressive activity of human seminal plasma and to the low immunogenicity of sperm.